Trial Profile
Randomized, Double-blind, Placebo-controlled Study of the Tolerability, and Pharmacokinetics of Fexinidazole After Single and Repeated Oral Ascending Doses, Completed by a Comparative Bioavailability Study of an Oral Suspension Versus a Tablet and an Exploratory Assessment of Food Effect, in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Fexinidazole (Primary)
- Indications African trypanosomiasis
- Focus Adverse reactions
- Sponsors Drugs for Neglected Diseases Initiative Foundation
- 22 Jan 2019 Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities from six trials published in the Antimicrobial Agents and Chemotherapy
- 15 Apr 2014 New trial record
- 18 Feb 2014 Results published in Clinical Pharmacokinetics.